First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer PatientsXin Zhou, Nan Li|Journal of Nuclear Medicine|2021Cited by 129
Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor VasculatureRui Bao, Zhaofei Liu, Yanpu Wang et al.|Molecular Pharmaceutics|2018Cited by 91
68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trialXiuling Shen, Nan Li|Nature Communications|2024Cited by 23
CTR-FAPI PET Enables Precision Management of Medullary Thyroid CarcinomaZiren Kong, Shaoyan Liu, Chenyan Gao et al.|Cancer Discovery|2024Cited by 23
Covalent FAPI PET enables accurate management of medullary thyroid carcinoma: A prospective single-arm comparative clinical trial.Ziren Kong, Shaoyan Liu, Li Zhu et al.|Journal of Clinical Oncology|2024Cited by 1